How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

2,236 results for

ADHD Resources

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

161. Brain Activity in Adults With ADHD During Neuropsychological Tasks

Control Time Perspective: Prospective Official Title: Brain Activity and Functional Connectivity in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) During Tasks of Motor Inhibition and Cognitive Switching Study Start Date : August 2015 Estimated Primary Completion Date : May 2017 Estimated Study Completion Date : August 2017 Resource links provided by the National Library of Medicine related topics: Groups and Cohorts Go to Group/Cohort Intervention/treatment Healthy volunteers healthy (...) Brain Activity in Adults With ADHD During Neuropsychological Tasks Brain Activity in Adults With ADHD During Neuropsychological Tasks - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Brain Activity in Adults

2015 Clinical Trials

162. Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)

-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD) Study Start Date : November 2015 Actual Primary Completion Date : March 2016 Actual Study Completion Date : March 2016 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: SHP465 12.5 mg Subjects will receive SHP465 12.5 mg Drug: SHP465 12.5mg capsules (one (...) Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD) Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number

2015 Clinical Trials

163. Examining Benefits of Modified Cogmed Training With ADHD at Cambridge Memorial Hospital(CMH)

Trial) Estimated Enrollment : 70 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Treatment Official Title: Examining Benefits of Modified Cogmed Training With ADHD Youth at Cambridge Memorial Hospital (CMH) Study Start Date : November 2015 Estimated Primary Completion Date : December 2018 Estimated Study Completion Date : December 2019 Resource links provided by the National Library of Medicine related topics: Arms (...) Examining Benefits of Modified Cogmed Training With ADHD at Cambridge Memorial Hospital(CMH) Examining Benefits of Modified Cogmed Training With ADHD at Cambridge Memorial Hospital(CMH) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more

2015 Clinical Trials

164. Effects of Nicotine Reduction on Smoking Behavior in ADHD Smokers

Effects of Nicotine Reduction on Smoking Behavior in ADHD Smokers Effects of Nicotine Reduction on Smoking Behavior in ADHD Smokers - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Effects of Nicotine (...) Reduction on Smoking Behavior in ADHD Smokers (ADHDenic) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT02599571 Recruitment Status : Recruiting First Posted : November 6, 2015 Last Update Posted : August 13, 2018 See

2015 Clinical Trials

165. Brain-Computer Interface-based Programme for the Treatment of ASD/ADHD

Brain-Computer Interface-based Programme for the Treatment of ASD/ADHD Brain-Computer Interface-based Programme for the Treatment of ASD/ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Brain-Computer (...) Interface-based Programme for the Treatment of ASD/ADHD (ASDBCI) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT02618135 Recruitment Status : Recruiting First Posted : December 1, 2015 Last Update Posted : August 2, 2017 See

2015 Clinical Trials

166. Evaluation of Use of Brain Activity Monitoring Dynamics in ADHD

With an Easy to Use EEG Actual Study Start Date : April 2016 Actual Primary Completion Date : October 2016 Actual Study Completion Date : January 2017 Resource links provided by the National Library of Medicine available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: Participants diagnosed with ADD/ADHD EEG monitoring (MindWave by NeuroSky and EPOC by Emotiv) and Methylphenidate administration Device: EEG monitoring (MindWave by NeuroSky) EEG evaluation will be conducted (...) Evaluation of Use of Brain Activity Monitoring Dynamics in ADHD Evaluation of Use of Brain Activity Monitoring Dynamics in ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Evaluation of Use of Brain

2015 Clinical Trials

167. Neurophysiological Attention Test (NAT) for Objective Assessment of Adult ADHD

Date : July 5, 2018 Resource links provided by the National Library of Medicine related topics: Groups and Cohorts Go to Group/Cohort Intervention/treatment ADHD: Adults with ADHD NAT electroencephalography (EEG) test Other: NAT electroencephalography (EEG) test Individuals in both groups are asked to perform standard behavioral tests and an electroencephalography (EEG) test. Controls: Healthy adults without ADHD NAT electroencephalography (EEG) test Other: NAT electroencephalography (EEG) test (...) the study research staff using the contacts provided below. For general information, Layout table for eligibility information Ages Eligible for Study: 18 Years to 40 Years (Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: Yes Sampling Method: Non-Probability Sample Study Population Adults with Attention Deficit Hyperactivity Disorder (ADHD) from local clinics, clinicians, ADHD community resources in the area of each of the three participating Universities (UCLA, UCB, OHSU) Criteria

2015 Clinical Trials

168. Working Memory Training and Neurofeedback for Children With ADHD, a Pilot Study

to Layout table for study information Study Type : Interventional (Clinical Trial) Actual Enrollment : 6 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Treatment Official Title: Working Memory Training and Neurofeedback for Children With ADHD, a Pilot Study Study Start Date : October 2014 Actual Primary Completion Date : June 2015 Actual Study Completion Date : June 2015 Resource links provided by the National Library of Medicine (...) Working Memory Training and Neurofeedback for Children With ADHD, a Pilot Study Working Memory Training and Neurofeedback for Children With ADHD, a Pilot Study - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more

2015 Clinical Trials

169. PK/PD Pediatric ADHD Classroom Study

PK/PD Pediatric ADHD Classroom Study PK/PD Pediatric ADHD Classroom Study - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. PK/PD Pediatric ADHD Classroom Study The safety and scientific validity (...) ): Thomas J. Spencer, MD, Massachusetts General Hospital Study Details Study Description Go to Brief Summary: The purpose of this study is to evaluate the association between blood drug levels and the corresponding scores of commonly used behavioral instruments based upon data collected following administration of three different methylphenidate hydrochloride extended-release drug products in children with ADHD. Condition or disease Intervention/treatment Phase Attention Deficit Hyperactivity Disorder

2015 Clinical Trials

170. Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

, Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) Study Start Date : August 2015 Actual Primary Completion Date : May 2016 Actual Study Completion Date : May 2016 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: CTN SR first, then Placebo Participants will receive CTN SR at a TDD of 400 mg followed by placebo (after washout (...) Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You

2015 Clinical Trials

171. A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD

Official Title: A Randomized, Phase 3, Double-Blind, Crossover Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD Study Start Date : September 2015 Actual Primary Completion Date : January 2017 Actual Study Completion Date : January 2017 Resource links provided by the National Library of Medicine available for: Arms and Interventions Go to Arm Intervention/treatment Active Comparator: PRC-063 Titration during which subjects will be titrated from a starting dose (...) A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more

2015 Clinical Trials

172. L-Threonic Acid Magnesium Salt (L-TAMS) in ADHD

L-Threonic Acid Magnesium Salt (L-TAMS) in ADHD L-Threonic Acid Magnesium Salt (L-TAMS) in ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. L-Threonic Acid Magnesium Salt (L-TAMS) in ADHD The safety (...) . Surman, MD, Massachusetts General Hospital Study Details Study Description Go to Brief Summary: This study is a 12-week, open-label pilot study to test the effects of MMFS-201-301 on cognition and function in adults with ADHD. Subjects may enter the trial on a stable dose of medication for ADHD, and MMFS-201-301 will be given. Subjects who do not enter on a stable dose of ADHD medication will receive MMFS-201-301 alone. Condition or disease Intervention/treatment Phase Attention Deficit/Hyperactivity

2015 Clinical Trials

173. A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Naturalistic Setting

A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Naturalistic Setting A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Naturalistic Setting - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) studies before adding more. A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Naturalistic Setting The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02520388 Recruitment Status : Completed First Posted : August 11, 2015 Results First Posted : October 3, 2018 Last Update Posted

2015 Clinical Trials

174. Effectiveness Study of a Behavioral Teacher Program Targeting ADHD Symptoms

Effectiveness Study of a Behavioral Teacher Program Targeting ADHD Symptoms Effectiveness Study of a Behavioral Teacher Program Targeting ADHD Symptoms - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Effectiveness Study of a Behavioral Teacher Program Targeting ADHD Symptoms The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02518711 Recruitment Status : Completed First Posted : August 10, 2015 Last Update Posted : August 10, 2015 Sponsor: VU University of Amsterdam Collaborators: Stichting Kinderpostzegels

2015 Clinical Trials

175. Integrated Treatment for Adolescents With ADHD

with other behavioral treatments to form a multicomponent treatment package for adolescents with co-occurring behavior problems. In addition, the family-based, patient-centered CASH-AA and MIP protocols could be delivered in conjunction with other family-based treatments or with individual approaches that flexibly include caregivers in multiple treatment sessions. This makes CASH-AA and MIP highly efficient clinical resources for addressing ADHD-related problems in any outpatient setting that serves (...) Integrated Treatment for Adolescents With ADHD Integrated Treatment for Adolescents With ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Integrated Treatment for Adolescents With ADHD (CASALEAP IT2A

2015 Clinical Trials

176. Identification of Neuropsychological, Genetic and Neuroimaging Markers and Treatment Response Predictors of ADHD

Official Title: Neuropsychological, Genetic and Neuroimaging Markers and Treatment Response Predictors of Attention-Deficit/Hyperactivity Disorder (ADHD) Study Start Date : February 2015 Estimated Primary Completion Date : December 2018 Estimated Study Completion Date : February 2020 Resource links provided by the National Library of Medicine related topics: available for: Groups and Cohorts Go to Group/Cohort Intervention/treatment ADHD group Children and adolescents who met the Diagnostic (...) Identification of Neuropsychological, Genetic and Neuroimaging Markers and Treatment Response Predictors of ADHD Identification of Neuropsychological, Genetic and Neuroimaging Markers and Treatment Response Predictors of ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved

2015 Clinical Trials

177. Dasotraline Pediatric ADHD Study

Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD) Study Start Date : April 2015 Actual Primary Completion Date : July 2016 Actual Study Completion Date : July 2016 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: Dasotraline 2 mg Dasotraline 2 mg Drug: Dasotraline Dasotraline 2 mg once daily Other Name: SEP-225289 Experimental: Dasotraline 4 mg Dasotraline 4 mg (...) Dasotraline Pediatric ADHD Study Dasotraline Pediatric ADHD Study - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Dasotraline Pediatric ADHD Study The safety and scientific validity of this study

2015 Clinical Trials

178. Explore the Association Between Neuropsychological Functions and ADHD Diagnosis and Comorbid Using Longitudinal Study in Preschool Children

Official Title: Explore the Association Between Neuropsychological Functions and ADHD Diagnosis and Comorbid Using Longitudinal Study in Preschool Children Study Start Date : October 2014 Estimated Primary Completion Date : August 2017 Estimated Study Completion Date : August 2017 Resource links provided by the National Library of Medicine related topics: Groups and Cohorts Go to Outcome Measures Go to Primary Outcome Measures : The error rate and hit reaction time in the judgements on color flanker (...) Explore the Association Between Neuropsychological Functions and ADHD Diagnosis and Comorbid Using Longitudinal Study in Preschool Children Explore the Association Between Neuropsychological Functions and ADHD Diagnosis and Comorbid Using Longitudinal Study in Preschool Children - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study

2015 Clinical Trials

179. This Study is a Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in a 1:1 Ratio of Adults With ADHD

/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD) Study Start Date : June 2015 Actual Primary Completion Date : January 2017 Actual Study Completion Date : January 2017 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Active Comparator: MDX Metadoxine Immediate-release/slow-release, bilayer tablet PO of 1400 mg, taken once daily for 10 weeks (...) This Study is a Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in a 1:1 Ratio of Adults With ADHD The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100

2015 Clinical Trials

180. Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)

) Primary Purpose: Treatment Official Title: A Phase 3, Randomized, Double-blind, Multi-center, Placebo Controlled, Dose-Optimization, Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD) Actual Study Start Date : June 18, 2015 Actual Primary Completion Date : February 16, 2016 Actual Study Completion Date : February 16, 2016 Resource links provided by the National Library of Medicine related topics: Arms and Interventions (...) Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD) Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You

2015 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>